429 related articles for article (PubMed ID: 2416868)
1. A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
Santoli D; Tweardy DJ; Ferrero D; Kreider BL; Rovera G
J Exp Med; 1986 Jan; 163(1):18-40. PubMed ID: 2416868
[TBL] [Abstract][Full Text] [Related]
2. Constitutive interleukin 2 production by the JURKAT human leukemic T cell line.
Pawelec G; Borowitz A; Krammer PH; Wernet P
Eur J Immunol; 1982 May; 12(5):387-92. PubMed ID: 6980126
[TBL] [Abstract][Full Text] [Related]
3. Constitutive production of B cell differentiation factor-like activity by human T and B cell lines.
Kanowith-Klein S; Saxon A; Uittenbogaart CH
Eur J Immunol; 1987 May; 17(5):593-8. PubMed ID: 3495441
[TBL] [Abstract][Full Text] [Related]
4. Purification of a suppressor lymphokine (SL) from a human T-cell line.
Abolhassani M; Muraki J; Chiao JW
Immunol Invest; 1989 Jul; 18(6):741-51. PubMed ID: 2767735
[TBL] [Abstract][Full Text] [Related]
5. Human suppressor factors constitutively produced by T-T cell hybridomas: functional and biochemical characterization.
Kunicka JE; Calvelli TA; Fox FE; Steinberg J; Telerman A; Platsoucas C
Hybridoma; 1989 Apr; 8(2):127-51. PubMed ID: 2785481
[TBL] [Abstract][Full Text] [Related]
6. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
Chiba K; Nishimura T; Hashimoto Y
J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
[TBL] [Abstract][Full Text] [Related]
7. Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor.
Sayers TJ; Ransom JH; Denn AC; Herberman RB; Ortaldo JR
J Immunol; 1986 Jul; 137(1):385-90. PubMed ID: 2423611
[TBL] [Abstract][Full Text] [Related]
8. Hybridoma-derived human suppressor factors: inhibition of growth of tumor cell lines and effect on cytotoxic cells.
Kunicka JE; Fox FE; Seki H; Oleszak EL; Platsoucas CD
Hum Antibodies Hybridomas; 1991 Jul; 2(3):160-9. PubMed ID: 1873505
[TBL] [Abstract][Full Text] [Related]
9. Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia.
Zhelev Z; Ohba H; Bakalova R; Hadjimitova V; Ishikawa M; Shinohara Y; Baba Y
Cancer Chemother Pharmacol; 2004 Mar; 53(3):267-75. PubMed ID: 14663628
[TBL] [Abstract][Full Text] [Related]
10. Production of collagen synthesis inhibitory lymphokine by human leukemic T-lymphocyte cell lines.
Jimenez SA; Rosenbloom J
Immunol Lett; 1985; 11(2):69-74. PubMed ID: 3878830
[TBL] [Abstract][Full Text] [Related]
11. Immunoregulatory factors from a human macrophage-like cell line. II. A human T-cell lymphokine-induced suppressor factor for lymphocyte proliferation.
Wilkins JA; Sigurdson L; Jordon Y; Rutherford WJ; Warrington RJ
Cell Immunol; 1983 Apr; 77(2):329-37. PubMed ID: 6601995
[TBL] [Abstract][Full Text] [Related]
12. Production of macrophage activating factor by human leukemic T cell lines.
Imai K; Suzuki Y; Harada T; Morikawa S; Tanaka A
Microbiol Immunol; 1985; 29(8):769-81. PubMed ID: 3906371
[TBL] [Abstract][Full Text] [Related]
13. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
[TBL] [Abstract][Full Text] [Related]
14. Characterization and partial purification of a non-interferon macrophage activating factor produced by human leukemic T cell line.
Kutsukake H; Imai K; Harada T; Morikawa S; Tanaka A
J Biochem; 1988 Apr; 103(4):661-6. PubMed ID: 3049565
[TBL] [Abstract][Full Text] [Related]
15. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
Kawano M; Iwato K; Kuramoto A
J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
[TBL] [Abstract][Full Text] [Related]
17. Induction of T-cell proliferation and enhancement of NK activity by supernatants from Con A-stimulated human peripheral blood mononuclear cells: a new lymphokine.
Rosloniec EF; Cleveland RP; Kaufman DB
Cell Immunol; 1986 Apr; 99(1):170-81. PubMed ID: 2428528
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte-derived differentiation-inducing factor inhibits proliferation of leukemic and normal hemopoietic cells.
Gullberg U; Nilsson E; Sarngadharan MG; Olsson I
Blood; 1986 Dec; 68(6):1333-8. PubMed ID: 3490886
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
20. Human leukemia cell maturation induced by a T-cell lymphokine isolated from medium conditioned by normal lymphocytes.
Leung K; Chiao JW
Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1209-13. PubMed ID: 3871947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
